: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Influenza

Free Subscription

Articles published in Vaccine
Retrieve available abstracts of 514 articles:
HTML format
Text format

Single Articles

February 2012

POLAND GA , Tosh PK
New influenza vaccines: Promises, perils, and pitfalls.
Vaccine. 2012;30:983-4.
PubMed Text format Related articles

January 2012

MCELHANEY JE , Zhou X, Talbot HK, Soethout E, et al
The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

VEEN RL , Loynachan AT, Mogler MA, Russell BJ, et al
Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

IORIO AM , Bistoni O, Galdiero M, Lepri E, et al
Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

POLISENA J , Chen Y, Manuel D
The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

LIU WM , Nahar TE, Jacobi RH, Gijzen K, et al
Impaired production of TNF-alpha by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

LEKCHAROENSUK P , Wiriyarat W, Petcharat N, Lekcharoensuk C, et al
Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

REED C , Meltzer MI, Finelli L, Fiore A, et al
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

CHIU SS , Chan KH, So LY, Chen R, et al
The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong.
Vaccine. 2012.
PubMed Text format Related articles Abstract available

December 2011

BRIEN S , Kwong JC, Buckeridge DL
The determinants of 2009 pandemic A/H1N1 influenza vaccination: A systematic review.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

YIM K , Miles B, Zinsou R, Prince G, et al
Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PYO HM , Masic A, Woldeab N, Embury-Hyatt C, et al
Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

NEWES-ADEYI G , Greece J, Bozeman S, Walker DK, et al
Active surveillance for influenza vaccine adverse events: The integrated vaccine surveillance system.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WILLIAMS TL , Pirkle JL, Barr JR
Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

VESIKARI T , Forsten A, Herbinger KH, Cioppa GD, et al
Safety and immunogenicity of an MF59((R))-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HARDELID P , Fleming DM, Andrews N, Barley M, et al
Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GUTHMANN JP , Fonteneau L, Bonmarin I, Levy-Bruhl D, et al
Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MATSUSHITA M , Takeuchi S, Kumagai N, Uehara Y, et al
Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LERTDUMRONGLUK P , Changsirikulchai S, Limkunakul C, Prachukthum P, et al
Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KARRON RA , Thumar B, Schappell E, Surman S, et al
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CARRARO G , Naso A, Montomoli E, Gasparini R, et al
Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: A pilot study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PITMAN RJ , White LJ, Sculpher M
Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WANG W , Suguitan AL Jr, Zengel J, Chen Z, et al
Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

EHRLICH HJ , Berezuk G, Fritsch S, Aichinger G, et al
Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ROPERO-ALVAREZ AM , Whittembury A, Kurtis HJ, Dos Santos T, et al
Pandemic influenza vaccination: Lessons learned from Latin America and the Caribbean.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HAKIM H , Allison KJ, Van De Velde LA, Li Y, et al
Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

AMBROSE CS , Wu X, Knuf M, Wutzler P, et al
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SANCHEZ-PAYA J , Hernandez-Garcia I, Garcia-Roman V, Camargo-Angeles R, et al
Influenza vaccination among healthcare personnel after pandemic influenza H1N1.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

AMOUR S , Voirin N, Regis C, Bouscambert-Duchamp M, et al
Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DELL'ERA L , Corona F, Daleno C, Scala A, et al
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

November 2011

NICOLSON C , Harvey R, Johnson R, Guilfoyle K, et al
An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SAMMON CJ , McGrogan A, Snowball J, de Vries CS, et al
Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: An analysis using the General Practice Research Database.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KELLY H , Mercer G, Cowling BJ
The association of seasonal influenza vaccination with pandemic influenza H1N1 2009 infection.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ROTH B , Mohr H, Enders M, Garten W, et al
Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PEREIRA JA , Quach S, Hamid JS, Heidebrecht CL, et al
Exploring the feasibility of integrating barcode scanning technology into vaccine inventory recording in seasonal influenza vaccination clinics.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PATEL A , Gray M, Li Y, Kobasa D, et al
Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

QUAN FS , Compans RW, Kang SM
Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

VAN KESSEL G , Geels MJ, de Weerd S, Buijs LJ, et al
Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CASTILLA J , Martinez-Artola V, Salcedo E, Martinez-Baz I, et al
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: Cohort and case-control study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ASANUMA H , Zamri NB, Sekine SI, Fukuyama Y, et al
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WOOD JM , Major D, Heath A, Newman RW, et al
Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KING JC JR , Beckett D, Snyder J, Cummings GE, et al
Direct and indirect impact of influenza vaccination of young children on school absenteeism.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DONG L , Liu F, Fairman J, Hong DK, et al
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TAMBYAH PA , Wilder-Smith A, Pavlova BG, Barrett PN, et al
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

STANBERRY LR , Simon JK, Johnson C, Robinson PL, et al
Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W(80)5EC combined with approved seasonal influenza antigens.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SMITH JH , Papania M, Knaus D, Brooks P, et al
Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LOEB M , Russell ML, Fonseca K, Webby R, et al
Comparison of multiple estimates of efficacy for influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KAPPES MA , Sandbulte MR, Platt R, Wang C, et al
Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ZAHARATOS GJ , Yu J, Pace C, Song Y, et al
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TOZZI AE , Gesualdo F, Ugazio AG
Parental perception of influenza in Italy: A web survey.
Vaccine. 2011.
PubMed Text format Related articles

GILCA V , De Serres G, Hamelin ME, Boivin G, et al
Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CAI Z , Zhang T, Wan XF
Antigenic distance measurements for seasonal influenza vaccine selection.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SACADURA-LEITE E , Sousa-Uva A, Rebelo-de-Andrade H
Antibody response to the influenza vaccine in healthcare workers.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

October 2011

HONG SH , Byun YH, Nguyen CT, Kim SY, et al
Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

REDELINGS MD , Piron J, Smith LV, Chan A, et al
Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KAPOSY C
The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

OMON E , Damase-Michel C, Hurault-Delarue C, Lacroix I, et al
Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: The results of a French prospective descriptive study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PENFOLD RB , Rusinak D, Lieu T, Shefer A, et al
Financing and systems barriers to seasonal influenza vaccine delivery in community settings.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MAMELUND SE , Riise Bergsaker MA
Vaccine history, gender and influenza vaccination in a household context.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PALACHE A
Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

STOWE J , Andrews N, Bryan P, Seabroke S, et al
Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BROWN C , Clayton-Boswell H, Chaves SS, Prill M, et al
Validity of parental report of influenza vaccination in young children seeking medical care.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ROSELLA L , Groenwold RH, Crowcroft NS
Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CATTOLI G , Fusaro A, Monne I, Coven F, et al
Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SIMON JK , Carter M, Pasetti MF, Sztein MB, et al
Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LORENZO ME , Hodgson A, Robinson DP, Kaplan JB, et al
Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BLOCK SL , Yi T, Sheldon E, Dubovsky F, et al
A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GILDEA S , Arkins S, Walsh C, Cullinane A, et al
A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings-A randomised blind study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HATAKEYAMA S , Iwatsuki-Horimoto K, Okamoto K, Nukui Y, et al
Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PARIANI E , Boschini A, Amendola A, Poletti R, et al
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

September 2011

YOUNG F , Marra F
A systematic review of intradermal influenza vaccines.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SCHNEIDER-OHRUM K , Giles BM, Weirback HK, Williams BL, et al
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SANTIAGO FW , Fitzgerald T, Treanor JJ, Topham DJ, et al
Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

YANG L , Ma S, Chen PY, He JF, et al
Influenza associated mortality in the subtropics and tropics: Results from three Asian cities.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

STITTELAAR KJ , Kroeze EJ, Rudenko L, Dhere R, et al
Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MILLER BL , Ahmed F, Lindley MC, Wortley PM, et al
Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: A national survey of US hospitals.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PRECIOSO AR , Miraglia JL, Campos LM, Goulart AC, et al
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ZHAO K , Shi X, Zhao Y, Wei H, et al
Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHRISTIAN LM , Iams JD, Porter K, Glaser R, et al
Inflammatory responses to trivalent influenza virus vaccine among pregnant women.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

STAAT MA , Griffin MR, Donauer S, Edwards KM, et al
Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KOK G , van Essen GA, Wicker S, Llupia A, et al
Planning for influenza vaccination in health care workers: An Intervention Mapping approach.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GUPTA NK , Sharma V, Dixit VK
Development and characterization of chitosan coated poly-(varepsilon-caprolacone) nanoparticulate system for effective immunization against influenza.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MAHNKE YD , Saqr A, Hazenfeld S, Brady RC, et al
Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HURLEY LP , Wortley P, Allison MA, Leary SO, et al
Seasonal influenza vaccination in adults: Practice and attitudes about collaborative delivery with community vaccinators.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HAMBIDGE SJ , Ross C, McClure D, Glanz J, et al
Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SHOAMANESH A , Traboulsee A
Acute disseminated encephalomyelitis following influenza vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MCEVOY SP
A retrospective survey of the safety of trivalent influenza vaccine among adults working in healthcare settings in south metropolitan Perth, Western Australia, in 2010.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HARADA Y , Ninomiya-Mori A, Takahashi Y, Shirakura M, et al
Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

COUSSENS PM , Smith KA, Weber PS, Colvin CJ, et al
Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WANG L , Qin Z, Pantin-Jackwood M, Faulkner O, et al
Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LI Y , Reddy K, Reid SM, Cox WJ, et al
Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DELLA CIOPPA G , Vesikari T, Sokal E, Lindert K, et al
Trivalent and quadrivalent MF59-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PHONGSAMART W , Sirisanthana V, Wittawatmongkol O, Maleesatharn A, et al
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HARA M , Hanaoka T, Mizushima T, Honma J, et al
Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

August 2011

KRAUT A , Graff L, McLean D
Behavioral change with influenza vaccination: Factors influencing increased uptake of the pandemic H1N1 versus seasonal influenza vaccine in health care personnel.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MAHMUD SM , Hammond G, Elliott L, Hilderman T, et al
Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: Population-based case-control study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MITRAKRISHNAN S , Ranjanie G, Thirunavakarasu T, Manjula C, et al
Seizures and retrograde amnesia with cerebrospinal fluid changes following H1N1 influenza vaccination.
Vaccine. 2011;29:6369-70.
PubMed Text format Related articles Abstract available

ARJONA MA , Elaziz KM, Lanzas JM, Allam MF, et al
Coverage and side effects of influenza A(H1N1) 2009 monovalent vaccine among primary health care workers.
Vaccine. 2011;29:6366-8.
PubMed Text format Related articles Abstract available

ANDREWS NJ , Walker WT, Finn A, Heath PT, et al
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ANDREWS N , Stowe J, Al-Shahi Salman R, Miller E, et al
Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: Self-controlled case series.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

COOPER C , Thorne A
Influenza vaccine Oculorespiratory syndrome incidence is reduced in HIV.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LEEB A , Carcione D, Richmond PC, Jacoby P, et al
Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ATMAR RL , Keitel WA, Quarles JM, Cate TR, et al
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

AMODIO E , Tramuto F, Maringhini G, Asciutto R, et al
Are medical residents a "core group" for future improvement of influenza vaccination coverage in health-care workers? A study among medical residents at the University Hospital of Palermo (Sicily).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GIRARD MP , Katz JM, Pervikov Y, Hombach J, et al
Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LENG J , Delgado HS, Kavita U, Jacobs A, et al
Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ESPOSITO S , Daleno C, Picciolli I, Tagliaferri L, et al
Immunogenicity and safety of intradermal influenza vaccine in children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MICHIELS B , Govaerts F, Remmen R, Vermeire E, et al
A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

XIA M , Tan M, Wei C, Zhong W, et al
A candidate dual vaccine against influenza and noroviruses.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LI K , Luo J, Wang C, He H, et al
alpha-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

JONES JC , Settles EW, Brandt CR, Schultz-Cherry S, et al
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TREANOR JJ , Sahly HE, King J, Graham I, et al
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok((R))) against influenza in healthy adults: A randomized, placebo-controlled trial.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHOE YJ , Cho H, Kim SN, Bae GR, et al
Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RAMSEY MA , Marczinski CA
College students' perceptions of H1N1 flu risk and attitudes toward vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHAN TC , Hung IF, Luk JK, Shea YF, et al
Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: A one-year prospective cohort study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

JONES FR , Gabitzsch ES, Xu Y, Balint JP, et al
Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HEIKKINEN T , Heinonen S
Effectiveness and safety of influenza vaccination in children: European perspective.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BLANCHARD-ROHNER G , Siegrist CA
Vaccination during pregnancy to protect infants against influenza: Why and why not?
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RIMMELZWAAN GF , Bodewes R, Osterhaus AD
Vaccination strategies to protect children against seasonal and pandemic influenza.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ESPOSITO S , Principi N
Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

NICHOL KL
Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FRAAIJ PL , Heikkinen T
Seasonal influenza: The burden of disease in children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GRANSTROM M , Voordouw AC
Registration of influenza vaccines for children in Europe.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LANTHIER PA , Huston GE, Moquin A, Eaton SM, et al
Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LOPEZ-MACIAS C , Ferat-Osorio E, Tenorio-Calvol A, Isibasi A, et al
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

July 2011

CHENG AC , Kotsimbos T, Kelly HA, Irving LB, et al
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHOR JS , Pada SK, Stephenson I, Goggins WB, et al
Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PATOIS E , Capelle MA, Gurny R, Arvinte T, et al
Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LAGLER H , Wenisch JM, Tobudic S, Gualdoni GA, et al
Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ABBAS MA , Spackman E, Fouchier R, Smith D, et al
H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KUETHER G , Dietrich B, Smith T, Peter C, et al
Atraumatic osteonecrosis of the humeral head after influenza A-(H1N1) v-2009 vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

VAN WIELINK R , Harmsen MM, Martens DE, Peeters BP, et al
MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MOLBAK K , Widgren K, Jensen KS, Ethelberg S, et al
Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark.
Vaccine. 2011;29 Suppl 2:B63-9.
PubMed Text format Related articles Abstract available

VALTAT S , Cori A, Carrat F, Valleron AJ, et al
Age distribution of cases and deaths during the 1889 influenza pandemic.
Vaccine. 2011;29 Suppl 2:B6-B10.
PubMed Text format Related articles Abstract available

ANDREASEN V , Simonsen L
The perils of using annual all-cause mortality data to estimate pandemic influenza burden.
Vaccine. 2011;29 Suppl 2:B49-55.
PubMed Text format Related articles Abstract available

SAGLANMAK N , Andreasen V, Simonsen L, Molbak K, et al
Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: Using epidemiological evidence to detect antigenic drift.
Vaccine. 2011;29 Suppl 2:B42-8.
PubMed Text format Related articles Abstract available

NOYMER A
The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: An age, period, cohort analysis.
Vaccine. 2011;29 Suppl 2:B38-41.
PubMed Text format Related articles Abstract available

SATTENSPIEL L
Regional patterns of mortality during the 1918 influenza pandemic in Newfoundland.
Vaccine. 2011;29 Suppl 2:B33-7.
PubMed Text format Related articles Abstract available

RIZZO C , Ajelli M, Merler S, Pugliese A, et al
Epidemiology and transmission dynamics of the 1918-19 pandemic influenza in Florence, Italy.
Vaccine. 2011;29 Suppl 2:B27-32.
PubMed Text format Related articles Abstract available

CHOWELL G , Viboud C, Simonsen L, Miller MA, et al
The 1918-1920 influenza pandemic in Peru.
Vaccine. 2011;29 Suppl 2:B21-6.
PubMed Text format Related articles Abstract available

ALONSO WJ , Nascimento FC, Acuna-Soto R, Schuck-Paim C, et al
The 1918 influenza pandemic in Florianopolis: A subtropical city in Brazil.
Vaccine. 2011;29 Suppl 2:B16-20.
PubMed Text format Related articles Abstract available

HONIGSBAUM M
The 'Russian' influenza in the UK: Lessons learned, opportunities missed.
Vaccine. 2011;29 Suppl 2:B11-5.
PubMed Text format Related articles Abstract available

DWYER DE
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.
Vaccine. 2011;29 Suppl 2:B56-62.
PubMed Text format Related articles Abstract available

SIMONSEN L , Viboud C, Chowell G, Andreasen V, et al
The need for interdisciplinary studies of historic pandemics.
Vaccine. 2011;29 Suppl 2:B1-5.
PubMed Text format Related articles

BERNSTEIN DI , Falloon J, Yi T
A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WEIL-OLIVIER C , Lina B
Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CAGLE C , To TL, Nguyen T, Wasilenko J, et al
Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SUN F , Zhang Y, Tian D, Zheng M, et al
Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population-A practical observation.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BELONGIA EA , Kieke BA, Donahue JG, Coleman LA, et al
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: Comparison of interim and final results.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RAY P , Black S, Shinefield H, Dillon A, et al
Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MONTO AS , Black S, Plotkin SA, Orenstein WA, et al
Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LIU YV , Massare MJ, Barnard DL, Kort T, et al
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MALTEZOU HC , Katerelos P, Mavrouli M, Lourida A, et al
Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SCOTT PD , Meng B, Marriott AC, Easton AJ, et al
Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BISH A , Yardley L, Nicoll A, Michie S, et al
Factors associated with uptake of vaccination against pandemic influenza: A systematic review.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PAILLET C , Forno G, Soldano N, Kratje R, et al
Statistical optimization of influenza H1N1 production from batch cultures of suspension Vero cells (sVero).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ABDELWHAB EM , Grund C, Aly MM, Beer M, et al
Multiple dose vaccination with heterologous H5N2 vaccine: Immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BULTS M , Beaujean DJ, Richardus JH, Steenbergen JE, et al
Pandemic influenza A (H1N1) vaccination in the Netherlands: Parental reasoning underlying child vaccination choices.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HENDRIKS J , Holleman M, de Boer O, de Jong P, et al
An international technology platform for influenza vaccines.
Vaccine. 2011;29 Suppl 1:A8-A11.
PubMed Text format Related articles Abstract available

PERDUE ML , Bright RA
United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
Vaccine. 2011;29 Suppl 1:A48-50.
PubMed Text format Related articles Abstract available

FRANCIS DP , Grohmann G
WHO influenza vaccine technology transfer initiative: Role and activities of the Technical Advisory Group.
Vaccine. 2011;29 Suppl 1:A45-7.
PubMed Text format Related articles Abstract available

RUDENKO L , van den Bosch H, Kiseleva I, Mironov A, et al
Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
Vaccine. 2011;29 Suppl 1:A40-4.
PubMed Text format Related articles Abstract available

HOA LK , Hiep LV, Be LV
Development of pandemic influenza vaccine production capacity in Viet Nam.
Vaccine. 2011;29 Suppl 1:A34-6.
PubMed Text format Related articles Abstract available

SURICHAN S , Wirachwong P, Supachaturas W, Utid K, et al
Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic.
Vaccine. 2011;29 Suppl 1:A29-33.
PubMed Text format Related articles Abstract available

PONCE-DE-LEON S , Velazquez-Fernandez R, Bugarin-Gonzalez J, Garcia-Banuelos P, et al
Domestic influenza vaccine production in Mexico: A state-owned and a multinational company working together for public health.
Vaccine. 2011;29 Suppl 1:A26-8.
PubMed Text format Related articles Abstract available

SUHARDONO M , Ugiyadi D, Nurnaeni I, Emelia I, et al
Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia.
Vaccine. 2011;29 Suppl 1:A22-5.
PubMed Text format Related articles Abstract available

FRIEDE M , Palkonyay L, Alfonso C, Pervikov Y, et al
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer.
Vaccine. 2011;29 Suppl 1:A2-7.
PubMed Text format Related articles Abstract available

DHERE R , Yeolekar L, Kulkarni P, Menon R, et al
A pandemic influenza vaccine in India: From strain to sale within 12 months.
Vaccine. 2011;29 Suppl 1:A16-21.
PubMed Text format Related articles Abstract available

MIYAKI C , Meros M, Precioso AR, Raw I, et al
Influenza vaccine production for Brazil: A classic example of successful North-South bilateral technology transfer.
Vaccine. 2011;29 Suppl 1:A12-5.
PubMed Text format Related articles Abstract available

LAFORCE FM
Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: A success story and a window into the future.
Vaccine. 2011;29 Suppl 1:A1.
PubMed Text format Related articles

June 2011

CASTILLA J , Moran J, Martinez-Artola V, Fernandez-Alonso M, et al
Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: Cohort and case control study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PUSHKO P , Pearce MB, Ahmad A, Tretyakova I, et al
Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ROSENKRANDS I , Vingsbo-Lundberg C, Bundgaard TJ, Lindenstrom T, et al
Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BENNETT KJ , Pumkam C, Probst JC
Rural-urban differences in the location of influenza vaccine administration.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KHURANA S , Larkin C, Verma S, Joshi MB, et al
Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RODRIGUEZ-RIEIRO C , Hernandez-Barrera V, Carrasco-Garrido P, de Andres AL, et al
Vaccination against 2008/2009 and 2009/2010 seasonal influenza in Spain: Coverage among high risk subjects, HCWs, immigrants and time trends from the 2005/2006 campaign.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MORAES TJ , Lin GH, Wen T, Watts TH, et al
Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FRENCK RW JR , Belshe R, Brady RC, Winokur PL, et al
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone((R))) administered by intradermal and intramuscular route in healthy adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HAKIM H , Gaur AH, McCullers JA
Motivating factors for high rates of influenza vaccination among healthcare workers.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

COTTE L , Voirin N, Richard C, Brochier C, et al
Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

POLAND GA
Sophiology, vaccinology, and the healing professions - A warning from ancient Greece?
Vaccine. 2011;29:4535-6.
PubMed Text format Related articles

GLASER MS , Chui S, Webber MP, Gustave J, et al
Predictors of acceptance of H1N1 influenza vaccination by FDNY firefighters and EMS workers.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

YANAGISAWA N , Kazuhiro M, Ajisawa A, Imamura A, et al
Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PARK KS , Seo YB, Lee JY, Im SJ, et al
Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CRUM-CIANFLONE NF , Iverson E, Defang G
Impact of the type of seasonal influenza vaccine on immune responses to the 2009 pandemic influenza A (H1N1) vaccine.
Vaccine. 2011.
PubMed Text format Related articles

KELLEY NS , Osterholm MT, Belongia EA
Serious methodological issues with the study by Gwini et al.
Vaccine. 2011;29:4183.
PubMed Text format Related articles

WEI HJ , Chang W, Lin SC, Liu WC, et al
Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FRENSING T , Seitz C, Heynisch B, Patzina C, et al
Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ZHU H , Ding X, Chen X, Yao P, et al
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DOUKAS J , Morrow J, Bellinger D, Hilgert T, et al
Nonclinical biodistribution, integration, and toxicology evaluations of an H5N1 pandemic influenza plasmid DNA vaccine formulated with Vaxfectin((R)).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

May 2011

BLYTH CC , Currie AJ, Wiertsema SP, Conway N, et al
Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TURLEY CB , Rupp RE, Johnson C, Taylor DN, et al
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LI R , Lim A, Ow ST, Phoon MC, et al
Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ABT M , de Jonge J, Laue M, Wolff T, et al
Improvement of H5N1 influenza vaccine viruses: Influence of internal gene segments of avian and human origin on production and hemagglutinin content.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BEYER WE , Nauta JJ, Palache AM, Giezeman KM, et al
Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MUNOZ MP , Soldevila N, Martinez A, Carmona G, et al
Influenza vaccine coverage, influenza-associated morbidity and all-cause mortality in Catalonia (Spain).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SCHWARZ TF , Flamaing J, Rumke HC, Penzes J, et al
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged >/=65 years.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SUNIL TS , Zottarelli LK
Student utilization of a university 2009 H1N1 vaccination clinic.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BHATTACHARYYA S , Bauch CT
"Wait and see" vaccinating behaviour during a pandemic: A game theoretic analysis.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MADHUN AS , Haaheim LR, Nostbakken JK, Ebensen T, et al
Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4(+) cells and strong mucosal and systemic antibody responses in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MCCARTHY NL , Gee J, Weintraub E, Donahue JG, et al
Monitoring vaccine safety using the Vaccine Safety Datalink: Utilizing immunization registries for pandemic influenza.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TENNIS P , Toback SL, Andrews E, McQuay LJ, et al
A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TAYLOR DN , Treanor JJ, Strout C, Johnson C, et al
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TAVARES F , Nazareth I, Monegal JS, Kolte I, et al
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

XUE W , Mattick D, Smith L
Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial vi
Vaccine. 2011.
PubMed Text format Related articles Abstract available

YAO X , Hamilton RG, Weng NP, Xue QL, et al
Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HUNG LH , Tsai PC, Wang CH, Li SL, et al
Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian influenza vaccine in chickens.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RISI G , Frenette L, Langley JM, Li P, et al
Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ORTIZ JR , Englund JA, Neuzil KM
Influenza vaccine for pregnant women in resource-constrained countries: A review of the evidence to inform policy decisions.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TUPPIN P , Samson S, Weill A, Ricordeau P, et al
Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RIDDA I , Seale H, Katelaris A, Heywood AE, et al
Pneumococcal colonisation following influenza infection.
Vaccine. 2011.
PubMed Text format Related articles

BOHMER MM , Walter D, Muters S, Krause G, et al
Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: Results from a national health update survey.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ADLER-MOORE J , Munoz M, Kim H, Romero J, et al
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

April 2011

CROWE S , Utley M, Walker G, Grove P, et al
A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza.
Vaccine. 2011.
PubMed Text format Related articles

CHEN SC , Hawkins G, Aspinall E, Patel N, et al
Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: Lessons for improving vaccination rates.
Vaccine. 2011.
PubMed Text format Related articles

AUDOUY SA , van der Schaaf G, Hinrichs WL, Frijlink HW, et al
Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.
Vaccine. 2011.
PubMed Text format Related articles

TORII Y , Kimura H, Ochi N, Kaneko K, et al
Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.
Vaccine. 2011.
PubMed Text format Related articles

MALLORY RM , Yi T, Ambrose CS
Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Vaccine. 2011.
PubMed Text format Related articles

FLOOD EM , Ryan KJ, Rousculp MD, Beusterien KM, et al
A survey of children's preferences for influenza vaccine attributes.
Vaccine. 2011.
PubMed Text format Related articles

GARCIA-SICILIA J , Gillard P, Carmona A, Tejedor JC, et al
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KURZ X , Domergue F, Slattery J, Segec A, et al
Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TANGUY M , Boyeau C, Pean S, Marijon E, et al
Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a French Teaching Hospital.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TOBACK SL , Herley J, Edelman L, Ambrose CS, et al
Trends in US pediatric influenza vaccination from 2006 to 2010 among children with private insurance.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ELZEN WP , Vossen AC, Cools HJ, Westendorp RG, et al
Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DAWOOD FS , Fry AM, Muangchana C, Sanasuttipun W, et al
A method for estimating vaccine preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HALASA N , Englund JA, Nachman S, Weinberg GA, et al
Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ELIASSON DG , Helgeby A, Schon K, Nygren C, et al
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

DIBIASE LM , Davis SE, Rosselli R, Horney J, et al
Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KELLY HA , Grant KA, Fielding JE, Carville KS, et al
Pandemic influenza H1N1 2009 infection in Victoria, Australia: No evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ASHRAF S , Kong W, Wang S, Yang J, et al
Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

WALTER D , Bohmer MM, Heiden MA, Reiter S, et al
Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - Results from thirteen consecutive cross-sectional surveys.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LEE DH , Park JK, Lee YN, Song JM, et al
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

March 2011

SEALE H , Leask J, Macintyre CR
Awareness, attitudes and behavior of hospital healthcare workers towards a mandatory vaccination directive: Two years on.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ROBIEN MA , Lifson AR, Duval S, Nichol KL, et al
Telephone survey assessment of household patterns of influenza vaccination, Twin Cities seven county metro area, 2008-2009.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHAUSSEE MS , Sandbulte HR, Schuneman MJ, Depaula FP, et al
Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FORREST BD , Steele AD, Hiemstra L, Rappaport R, et al
A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HELMS C , Polgreen P, Polgreen L, Evans T, et al
Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: The impact of a four year provider-based statewide performance improvement project.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

TERESA DC , Miguel VJ, Susana C, Ana G, et al
2009-2010 seasonal and pandemic A (H1N1) influenza vaccination among healthcare workers.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GILDEA S , Arkins S, Walsh C, Cullinane A, et al
A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt Horses - a randomised blind study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MEIER S , Bel M, L'huillier A, Crisinel PA, et al
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

NAKOWITSCH S , Wolschek M, Morokutti A, Ruthsatz T, et al
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MICHAELIDIS CI , Zimmerman RK, Nowalk MP, Smith KJ, et al
Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LORBETSKIE B , Wang J, Gravel C, Allen C, et al
Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CRISTINA C , Marco T, Pasquale P, Alessandro S, et al
Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

POLAND GA
The day that Jack died.
Vaccine. 2011;29:2227-8.
PubMed Text format Related articles

RIMMELZWAAN GF , Joyce Verburgh R, Nieuwkoop NJ, Bestebroer TM, et al
Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MILLER EK , Dumitrescu L, Cupp C, Dorris S, et al
Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BABIUK S , Masic A, Graham J, Neufeld J, et al
An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ZHOU X , McElhaney JE
Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans.
Vaccine. 2011;29:2169-77.
PubMed Text format Related articles Abstract available

TALAAT KR , Karron RA, Luke CJ, Thumar B, et al
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ALKUWARI MG , Aziz NA, Nazzal ZA, Al-Nuaimi SA, et al
Pandemic influenza A/H1N1 vaccination uptake among health care workers in Qatar: motivators and barriers.
Vaccine. 2011;29:2206-11.
PubMed Text format Related articles Abstract available

BAILEY TM , Haines C, Rosychuk RJ, Marrie TJ, et al
Public engagement on ethical principles in allocating scarce resources during an influenza pandemic.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

February 2011

CRUM-CIANFLONE NF , Iverson E, Defang G, Blair PJ, et al
Durability of antibody responses after receipt of the monovalent 2009 influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MURATA H , Macauley J, Lewis AM Jr, Peden K, et al
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHEN WH , Cross AS, Edelman R, Sztein MB, et al
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KOSALARAKSA P , Srirompotong U, Newman RW, Lumbiganon P, et al
Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FABBIANI M , Di Giambenedetto S, Sali M, Farina S, et al
Immune response to influenza A (H1N1) monovalent MF59-adjuvanted vaccine in HIV-infected patients.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SCHANEN BC , De Groot AS, Moise L, Ardito M, et al
Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PETOUSIS-HARRIS H , Poole T, Booy R, Turner N, et al
Fever following administration of two inactivated influenza vaccines-A survey of parents of New Zealand infants and children 5 years of age and under.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PEARCE MB , Belser JA, Houser KV, Katz JM, et al
Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

JIMENEZ-GARCIA R , Rodriguez-Rieiro C, Hernandez-Barrera V, Andres AL, et al
Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HARRIS K , Maurer J, Black C, Euler G, et al
Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1).
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PICHICHERO ME
Response to Letter to the Editor: Detection of naturally occurring antibodies against Protein D of Haemophilus influenza by Mustafa Akkoyunlu.
Vaccine. 2011.
PubMed Text format Related articles

DOWER J , Donald M, Begum N, Vlack S, et al
Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

AGGARWAL K , Jing F, Maranga L, Liu J, et al
Bioprocess optimization for cell culture based influenza vaccine production.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

EASTON AJ , Scott PD, Edworthy NL, Meng B, et al
A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

KRUIJSEN D , Schijf MA, Lukens MV, van Uden NO, et al
Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

NGUYEN DC , Masseoud F, Lu X, Scinicariello F, et al
17beta-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GAUGER PC , Vincent AL, Loving CL, Lager KM, et al
Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LUO M , Qu X, Pan R, Zhu D, et al
The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SMITH JH , Brooks P, Johnson S, Tompkins SM, et al
Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ORIA PA , Matini W, Nelligan I, Emukule G, et al
Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pande
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MAYET A , Ligier C, Gache K, Manet G, et al
Adverse events following pandemic influenza vaccine Pandemrix((R)) reported in the French military forces-2009-2010.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HAYWARD AC , Watson J
Effectiveness of influenza vaccination of staff on morbidity, and mortality of residents of long term care facilities for the elderly.
Vaccine. 2011.
PubMed Text format Related articles

January 2011

PEBODY R , Andrews N, Waight P, Malkani R, et al
No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SULTANA I , Gao J, Markoff L, Eichelberger MC, et al
Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

BAXTER R , Patriarca PA, Ensor K, Izikson R, et al
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok((R)) trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

RUBIN GJ , Potts HW, Michie S
Likely uptake of swine and seasonal flu vaccines among healthcare workers. A cross-sectional analysis of UK telephone survey data.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HATTA Y , Hatta M, Bilsel P, Neumann G, et al
An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

CHOE YJ , Cho H, Bae GR, Lee JK, et al
Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

POLAND GA
Pandemic 2009-2010 influenza vaccine: Six lessons learned and the way forward (Allegro not Adagio).
Vaccine. 2011;29:613-4.
PubMed Text format Related articles

LIU H , Bungener L, Ter Veer W, Coller BA, et al
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

EVEN-OR O , Joseph A, Itskovitz-Cooper N, Samira S, et al
A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GRUND C , Abdelwhab ES, Arafa AS, Ziller M, et al
Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

HARMARK L , van Hunsel F, Hak E, van Grootheest K, et al
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

MONTASTRUC JL , Durrieu G, Rascol O
Pandemrix degrees , (H1N1)v influenza and reported cases of narcolepsy.
Vaccine. 2011.
PubMed Text format Related articles

LANGLEY JM , Aoki F, Ward BJ, McGeer A, et al
A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FERDINANDS JM , Belongia EA, Nwasike C, Shay DK, et al
Influenza vaccination status is not associated with influenza testing among children: Implications for observational studies of vaccine effectiveness.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LOEFFEN WL , de Vries RP, Stockhofe N, van Zoelen-Bos D, et al
Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PLENNEVAUX E , Blatter M, Cornish MJ, Go K, et al
Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FABRY P , Gagneur A, Pasquier JC
Determinants of A (H1N1) vaccination: Cross-sectional study in a population of pregnant women in Quebec.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

EZOE H , Akeda Y, Piao Z, Aoshi T, et al
Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FEEMSTER KA , Prasad P, Smith MJ, Feudtner C, et al
Employee designation and health care worker support of an influenza vaccine mandate at a large pediatric tertiary care hospital.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ENGELHARD D , Zakay-Rones Z, Shapira MY, Resnick I, et al
The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ZHANG T , Zhao PS, Zhang W, Liang M, et al
Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

LEE BY , Bacon K, Donohue JM, Wiringa AE, et al
From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SEALE H , Kaur R, Wang Q, Yang P, et al
Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

ARAD U , Tzadok S, Amir S, Mandelboim M, et al
The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

SCHEIBLE K , Zhang G, Baer J, Azadniv M, et al
CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

PILLET S , Kobasa D, Meunier I, Gray M, et al
Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

GAVAZZI G , Filali-Zegzouti Y, Guyon AC, De Wazieres B, et al
French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: The VESTA study.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

FARNSWORTH A , Cyr TD, Li C, Wang J, et al
Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.
Vaccine. 2011.
PubMed Text format Related articles Abstract available

December 2010

SONG JY , Cheong HJ, Heo JY, Noh JY, et al
Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

AMODIO E , Anastasi G, Marsala MG, Torregrossa MV, et al
Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ESPOSITO S , Tagliaferri L, Daleno C, Valzano A, et al
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ROBERTSON JS , Nicolson C, Harvey R, Johnson R, et al
The development of vaccine viruses against pandemic A(H1N1) influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KATAYOSE M , Hosoya M, Haneda T, Yamaguchi H, et al
The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SIPO I , Knauf M, Fechner H, Poller W, et al
Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MALLICK AI , Parvizi P, Read LR, Nagy E, et al
Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SAWADA A , Komase K, Nakayama T
AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PEREIRA CC , Mulligan M, Bridges JF, Bishai D, et al
Determinants of influenza vaccine purchasing decision in the US: A conjoint analysis.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TREMBLAY CL , Rouleau D, Fortin C, Toma E, et al
Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LACROIX I , Damase-Michel C, Kreft-Jais C, Castot A, et al
2009 H1N1 influenza vaccines in pregnant women: The French Pharmacovigilance survey.
Vaccine. 2010.
PubMed Text format Related articles

RODRIGUEZ-RIEIRO C , Esteban-Vasallo MD, Dominguez-Berjon MF, Astray-Mochales J, et al
Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GWINI SM , Coupland CA, Siriwardena AN
The effect of influenza vaccination on risk of acute myocardial infarction: Self-controlled case-series study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FOLKENBERG M , Callreus T, Svanstrom H, Valentiner-Branth P, et al
Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SAKKOU Z , Stripeli F, Papadopoulos NG, Critselis E, et al
Impact of influenza infection on children's hospital admissions during two seasons in Athens, Greece.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HWANG SD , Kim HS, Cho SW, Seo SH, et al
Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

JAVELLE E , Soulier B, Brosset C, Lorcy S, et al
Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VELAN B , Kaplan G, Ziv A, Boyko V, et al
Major motives in non-acceptance of A/H1N1 flu vaccination: The weight of rational assessment.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LOEBERMANN M , Anders G, Brestrich G, Fritzsche C, et al
Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

COLOMBATTI R , Perrotta S, Masera N, Palazzi G, et al
Lessons learned from the H1N1 pandemic: The need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WU J , Zhong X, Li CK, Zhou JF, et al
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

November 2010

ABELIN A , Colegate T, Gardner S, Hehme N, et al
Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CARVAJAL A , Ortega PG, Sainz M, Velasco V, et al
Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

STEFFEN C , Diop OM, Gessner BD, Hacen MM, et al
Afriflu-International conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHAO DY , Cheng KF, Hsieh YH, Li TC, et al
Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

COLEMAN LA , Kieke B, Irving S, Shay DK, et al
Comparison of influenza vaccine effectiveness using different methods of case detection: Clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LEE YS , Lee KA, Lee JY, Kang MH, et al
An alpha-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LU CC , Wang YC, Lai JH, Lee TS, et al
A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: Safety and immunity.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HANQUET G , van Damme P, Brasseur D, de Cuyper X, et al
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHEONG HJ , Song JY, Heo JY, Noh JY, et al
Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

JIT M , Cromer D, Baguelin M, Stowe J, et al
The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CROWE BA , Bruhl P, Gerencer M, Schwendinger MG, et al
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KWON Y , Cho HY, Lee YK, Bae GR, et al
Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GRIJALVA CG , Zhu Y, Simonsen L, Griffin MR, et al
Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SUBBRAMANIAN RA , Basha S, Shata MT, Brady RC, et al
Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

October 2010

CAMPITELLI MA , Rosella LC, Stukel TA, Kwong JC, et al
Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MADHUN AS , Akselsen PE, Sjursen H, Pedersen G, et al
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BOESTEANU AC , Babu NS, Wheatley M, Papazoglou ES, et al
Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GAYGISIZ U , Gaygisiz E, Ozkan T, Lajunen T, et al
Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FRASCA D , Diaz A, Romero M, Landin AM, et al
Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MCLENNAN S , Wicker S
Reflections on the influenza vaccination of healthcare workers.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TREANOR JJ , Taylor DN, Tussey L, Hay C, et al
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BUDIMIR N , Meijerhof T, Wilschut J, Huckriede A, et al
The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HELDENS JG , Glansbeek HL, Hilgers LA, Haenen B, et al
Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HIDIROGLU S , Ay P, Topuzoglu A, Kalafat C, et al
Resistance to vaccination: The attitudes and practices of primary healthcare workers confronting the H1N1 pandemic.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SALUJA V , Visser MR, Ter Veer W, van Roosmalen ML, et al
Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

YAO Q , Fischer KP, Li L, Agrawal B, et al
Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

THOMAS RE , Jefferson T, Lasserson TJ
Influenza vaccination for healthcare workers who work with the elderly: Systematic review.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BONE A , Guthmann JP, Nicolau J, Levy-Bruhl D, et al
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: Results of a national vaccination campaign.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KING JC JR , Lichenstein R, Cummings GE, Magder LS, et al
Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LIAO YC , Chen FC, Hsiung CA
Contrasting substitution patterns between HA proteins of avian and human influenza viruses: Implication for monitoring human influenza epidemics.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

September 2010

ESPOSITO S , D'Angelo E, Daleno C, Peia F, et al
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with beta-thalassemia major.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VARELLA A
Report of the international forum on pandemic influenza 2010 Qingdao, China, 24-25 July 2010.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SMITH KJ , Lee BY, Nowalk MP, Raymund M, et al
Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHEN CY , Liu HJ, Tsai CP, Chung CY, et al
Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SCHMIDT MA , Crane B, Mullooly JP, Naleway AL, et al
Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PUIG-BARBERA J , Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, et al
Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SUI Z , Chen Q, Fang F, Zheng M, et al
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

QUACH S , Hamid JS, Pereira JA, Heidebrecht CL, et al
Time and motion study to compare electronic and hybrid data collection systems during the pandemic (H1N1) 2009 influenza vaccination campaign.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VALENCIANO M , Kissling E, Ciancio BC, Moren A, et al
Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BOGGILD AK , Castelli F, Gautret P, Torresi J, et al
Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VELLOZZI C , Broder KR, Haber P, Guh A, et al
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009-January 31, 2010.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BUGARINI R , Casula D, Groth N, Lattanzi M, et al
Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: Application of a re-sampling method on a large phase III influenza vaccine clinical trial.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BROWN LE
The role of adjuvants in vaccines for seasonal and pandemic influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GOSBELL IB , Gottlieb T, Kesson AM, Post JJ, et al
Immunisation and multi-dose vials.
Vaccine. 2010;28:6556-61.
PubMed Text format Related articles Abstract available

CAMILLONI B , Neri M, Lepri E, Basileo M, et al
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ELLEBEDY AH , Ducatez MF, Duan S, Stigger-Rosser E, et al
Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

USCHER-PINES L , Maurer J, Kellerman A, Harris KM, et al
Healthy young and middle age adults: What will it take to vaccinate them for influenza?
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LIM SH , Lee JH, Kim BC, Jung SU, et al
Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BAXTER R , Ray GT, Fireman BH
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SURLS J , Nazarov-Stoica C, Kehl M, Casares S, et al
Differential effect of CD4(+)Foxp3(+) T-regulatory cells on the B and T helper cell responses to influenza virus vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BELSHE RB
The need for quadrivalent vaccine against seasonal influenza.
Vaccine. 2010;28 Suppl 4:D45-53.
PubMed Text format Related articles Abstract available

MONTO AS
Seasonal influenza and vaccination coverage.
Vaccine. 2010;28 Suppl 4:D33-44.
PubMed Text format Related articles Abstract available

POLAND GA
The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.
Vaccine. 2010;28 Suppl 4:D3-13.
PubMed Text format Related articles Abstract available

FALSEY AR
New emerging technologies and the intradermal route: the novel way to immunize against influenza.
Vaccine. 2010;28 Suppl 4:D24-32.
PubMed Text format Related articles Abstract available

MONTO AS
Seasonal influenza vaccinations: specialized products for different target groups.
Vaccine. 2010;28 Suppl 4:D14-23.
PubMed Text format Related articles Abstract available

POLAND GA
Putting the puzzle pieces together: the dynamic landscape of influenza vaccine and policy.
Vaccine. 2010;28 Suppl 4:D1-2.
PubMed Text format Related articles

ROLLAND-HARRIS E , Tepper M
Cost-effectiveness of Ontario's pandemic vaccine program.
Vaccine. 2010.
PubMed Text format Related articles

KUNG HC , Huang KC, Kao TM, Lee YC, et al
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BARRIERE J , Vanjak D, Kriegel I, Otto J, et al
Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

August 2010

MURATA Y , Lightfoote PM, Biear JN, Falsey AR, et al
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.
Vaccine. 2010;28:6242-6.
PubMed Text format Related articles Abstract available

SANDER B , Bauch CT, Fisman D, Fowler RA, et al
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
Vaccine. 2010;28:6210-20.
PubMed Text format Related articles Abstract available

BLACK S , Della Cioppa G, Malfroot A, Nacci P, et al
Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ZHANG J , While AE, Norman IJ
Knowledge and attitudes regarding influenza vaccination among nurses: A research review.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HUANG WT , Chen WW, Yang HW, Chen WC, et al
Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ANDREWS N , Stowe J, Wise L, Miller E, et al
Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHU C , Lugovtsev V, Lewis A, Betenbaugh M, et al
Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ZHAO G , Du L, Xiao W, Sun S, et al
Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CARLSON SJ , Durrheim DN, Dalton CB
Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HELDENS JG , Pouwels HG, Derks CG, Van de Zande SM, et al
Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

RUDOLF M , Poppel M, Frohlich A, Breithaupt A, et al
Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TANG XC , Lu HR, Ross TM
Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

POLAND GA
Mandating influenza vaccination for health care workers: Putting patients and professional ethics over personal preference.
Vaccine. 2010;28:5757-9.
PubMed Text format Related articles

KAWAKAMI K , Ohkusa Y, Kuroki R, Tanaka T, et al
Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LEE VJ , Tay JK, Chen MI, Phoon MC, et al
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MORELON E , Noble CP, Daoud S, Cahen R, et al
Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MASIC A , Lu X, Li J, Mutwiri GK, et al
Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HEYNISCH B , Frensing T, Heinze K, Seitz C, et al
Differential activation of host cell signalling pathways through infection with two variants of influenza A/PR/8/34 (H1N1) in MDCK cells.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

AMEISS K , Ashraf S, Kong W, Pekosz A, et al
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FENG L , Mounts AW, Feng Y, Luo Y, et al
Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

THUENG-IN K , Maneewatch S, Srimanote P, Songserm T, et al
Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

July 2010

SEALY R , Jones BG, Surman SL, Hurwitz JL, et al
Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ZIMMERMAN RK , Lauderdale DS, Tan SM, Wagener DK, et al
Prevalence of high-risk indications for influenza vaccine varies by age, race, and income.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ESPOSITO S , Marchisio P, Ansaldi F, Bianchini S, et al
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GIRARD MP , Katz J, Pervikov Y, Palkonyay L, et al
Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

JIMENEZ-GARCIA R , Hernandez-Barrera V, de Andres AL, Jimenez-Trujillo I, et al
Gender influence in influenza vaccine uptake in Spain: Time trends analysis (1995-2006).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KAO TM , Hsieh SM, Kung HC, Lee YC, et al
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

OPSTELTEN W , van Essen GA, Heijnen ML, Ballieux MJ, et al
High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LANGLEY WA , Li ZN, Bradley KC, Talekar GR, et al
The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FOTY RG , Guttmann A, Kwong JC, Maaten S, et al
Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LAPPHRA K , Dobson S, Bettinger J
Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

RODRIGUEZ-RIEIRO C , Dominguez-Berjon MF, Esteban-Vasallo MD, Sanchez-Perruca L, et al
Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: Analysis of population registries in primary care in Madrid (Spain).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SHAHID Z , Kleppinger A, Gentleman B, Falsey AR, et al
Clinical and immunologic predictors of influenza illness among vaccinated older adults.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WU J , Liu SZ, Dong SS, Dong XP, et al
Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I-II randomized trial.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LIN CJ , Nowalk MP, Toback SL, Rousculp MD, et al
Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PETERSSON P , Hedenskog M, Alves D, Brytting M, et al
The Eurocine((R)) L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

DEDOUKOU X , Nikolopoulos G, Maragos A, Giannoulidou S, et al
Attitudes towards vaccination against seasonal influenza of health-care workers in primary health-care settings in Greece.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

REEMERS SS , Jansen C, Koerkamp MJ, van Haarlem D, et al
Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GRAVEL C , Li C, Wang J, Hashem AM, et al
Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LEE BY , Bailey RR, Wiringa AE, Afriyie A, et al
Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VENKAT A , Chan-Tompkins NH, Hegde GG, Chuirazzi DM, et al
Feasibility of integrating a clinical decision support tool into an existing computerized physician order entry system to increase seasonal influenza vaccination in the emergency department.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

June 2010

LU CY , Shao PL, Chang LY, Huang YC, et al
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HARA M , Tanaka K, Kase T, Maeda A, et al
Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MISPLON JA , Lo CY, Gabbard JD, Tompkins SM, et al
Genetic control of immune responses to influenza A matrix 2 protein (M2).
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KEAWCHAROEN J , Spronken MI, Vuong O, Bestebroer TM, et al
Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TORUN SD , Torun F
Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

OH CE , Lee J, Kang JH, Hong YJ, et al
Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LIN J , Somanathan S, Roy S, Calcedo R, et al
Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CARMONA A , Omenaca F, Tejedor JC, Merino JM, et al
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SONG H , Wittman V, Byers A, Tapia T, et al
In vitro stimulation of human influenza-specific CD8(+) T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

STEGMANN T , Kamphuis T, Meijerhof T, Goud E, et al
Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KRAIGHER A , Ucakar V
Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BOZZOLA E , Krzysztofiak A, Lancella L, Tozzi A, et al
Risk factors of complicated H1N1 influenza in hospitalized Italian children.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KANAI Y , Boonsathorn N, Chittaganpitch M, Bai G, et al
The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LAU JT , Cai Y, Tsui HY, Choi KC, et al
Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ORELLANO PW , Reynoso JI, Carlino O, Uez O, et al
Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VAN DER WEIJDEN CP , Bredenoord AL, van Delden JJ
The duty to treat in the context of an influenza pandemic.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SY LS , Liu IL, Solano Z, Cheetham TC, et al
Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PEARTON M , Kang SM, Song JM, Kim YC, et al
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

May 2010

FAIRBROTHER G , Cassedy A, Ortega-Sanchez IR, Szilagyi PG, et al
High costs of influenza: Direct medical costs of influenza disease in young children.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

STITTELAAR KJ , Lacombe V, van Lavieren R, van Amerongen G, et al
Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GIRARD MP , Tam JS, Assossou OM, Kieny MP, et al
The 2009 A (H1N1) influenza virus pandemic: A review.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HENS N , Van Ranst M, Aerts M, Robesyn E, et al
Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: A multi-country analysis for influenza A/H1N1v 2009.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LOOIJMANS-VAN DEN AKKER I , van Delden JJ, Verheij TJ, van der Sande MA, et al
Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TAMURA SI
Studies on the usefulness of intranasal inactivated influenza vaccines.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PALMER LA , Rousculp MD, Johnston SS, Mahadevia PJ, et al
Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PARTRIDGE J , Kieny MP
Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LEE BY , Brown ST, Korch G, Cooley PC, et al
A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

YANG CF , Belshe RB, Kemble G, Song E, et al
Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WICKER S , Rabenau HF
The reluctance of nurses to get vaccinated against influenza.
Vaccine. 2010.
PubMed Text format Related articles

VIRSEDA S , Restrepo MA, Arranz E, Magan-Tapia P, et al
Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PUSHKO P , Kort T, Nathan M, Pearce MB, et al
Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

EGGERT D , Thomas C, Spackman E, Pritchard N, et al
Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LAU JT , Yeung NC, Choi KC, Cheng MY, et al
Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

COHEN SA , Ahmed S, Klassen AC, Agree EM, et al
Childhood Hib vaccination and pneumonia and influenza burden in US seniors.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BLANK DL , Bodansky DM, Forbes A, Garde E, et al
Influenza vaccination of future healthcare workers: A cross-sectional study of uptake, knowledge and attitudes.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WONG LP , Sam IC
Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LEGUTKI JB , Magee DM, Stafford P, Johnston SA, et al
A general method for characterization of humoral immunity induced by a vaccine or infection.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WALTER EB , Rajagopal S, Zhu Y, Neuzil KM, et al
Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally?
Vaccine. 2010.
PubMed Text format Related articles Abstract available

REHMANI R , Memon JI
Knowledge, attitudes and beliefs regarding influenza vaccination among healthcare workers in a Saudi hospital.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

April 2010

ANSALDI F , Zancolli M, Paolo D, Montomoli E, et al
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BAATEN BJ , Clarke B, Strong P, Hou S, et al
Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BROWN KF , Kroll JS, Hudson MJ, Ramsay M, et al
Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHUAYCHOO B , Wongsurakiat P, Nana A, Kositanont U, et al
The immunogenicity of intradermal influenza vaccination in COPD patients.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FLASTERSTEIN OE , Samira S, Rochlin E, Balasingam S, et al
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LILJEBJELKE KA , Petkov DI, Kapczynski DR
Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

PRIETO-LARA E , Mendez AL
Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHEN Z , Zhou H, Jin H
The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

STEPHENSON I , Hayden F, Osterhaus A, Howard W, et al
Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SONG JY , Cheong HJ, Hwang IS, Choi WS, et al
Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ZHANG T , Wang CY, Zhang W, Gao YW, et al
Generation and characterization of a fusion protein of single-chain fragment variable antibody against hemagglutinin antigen of avian influenza virus and truncated protamine.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

FUSCO D , Liu X, Salvatore M, Savage C, et al
Echinacea purpurea aerial extract alters course of influenza infection in mice.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

XUE W , Ellis J, Mattick D, Smith L, et al
Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young ca
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHLIBEK R , Anca I, Andre F, Bakir M, et al
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

POLAND GA , Morse D
Improving the public health: the U.S. recommendation for universal influenza immunization.
Vaccine. 2010;28:2799-800.
PubMed Text format Related articles

March 2010

MOLLOY GJ
Increasing influenza vaccination rates: Where is the behaviour change theory?
Vaccine. 2010.
PubMed Text format Related articles

KIM S , Jang JE, Yu JR, Chang J, et al
Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

LE RU A , Jacob D, Transfiguracion J, Ansorge S, et al
Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HUSSAIN AI , Cordeiro M, Sevilla E, Liu J, et al
Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cel
Vaccine. 2010.
PubMed Text format Related articles Abstract available

RIZZO C , Rota MC, Bella A, Alfonsi V, et al
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

RIFFAULT S , Meyer G, Deplanche M, Dubuquoy C, et al
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HALLILEY JL , Kyu S, Kobie JJ, Walsh EE, et al
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

TENBUSCH M , Grunwald T, Niezold T, Bonsmann MS, et al
Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

GIJZEN K , Liu WM, Visontai I, Oftung F, et al
Standardization and validation of assays determining cellular immune responses against influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

February 2010

LI Z , Doan Q, Dobson S
Determinants of influenza immunization uptake in Canadian youths.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CAILLET C , Piras F, Bernard MC, de Montfort A, et al
AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BETTINGER JA , Sauve LJ, Scheifele DW, Moore D, et al
Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

MACHADO AV , Caetano BC, Barbosa RP, Salgado AP, et al
Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HULL HF
LAIV efficacy in military recruits.
Vaccine. 2010;28:2066.
PubMed Text format Related articles

HWANG SD , Shin JS, Ku KB, Kim HS, et al
Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

HARTGROVES LC , Koudstaal W, McLeod C, Moncorge O, et al
Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ZHU W , Higgs BW, Morehouse C, Streicher K, et al
A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

RICHARD SA , Viboud C, Miller MA
Evaluation of Southern Hemisphere influenza vaccine recommendations.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SAVULESCU C , Valenciano M, de Mateo S, Larrauri A, et al
Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups, 2008-2009 season, Spain.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SCHAAP-NUTT A , Scull MA, Schmidt AC, Murphy BR, et al
Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KRASHIAS G , Simon K, Wegmann F, Kok WL, et al
Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

VINCENT AL , Ciacci-Zanella JR, Lorusso A, Gauger PC, et al
Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

January 2010

MIYAKI C , Quintilio W, Miyaji EN, Botosso VF, et al
Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SCHWARZINGER M , Verger P, Guerville MA, Aubry C, et al
Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public?
Vaccine. 2010.
PubMed Text format Related articles Abstract available

ARANDA-ROMO S , Comas-Garcia A, Garcia-Sepulveda CA, Hernandez-Salinas AE, et al
Effect of an immunization program on seasonal influenza hospitalizations in Mexican children.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SMITH LR , Wloch MK, Ye M, Reyes LR, et al
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

WU J , Zhang F, Fang F, Chang H, et al
Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

DESANTE JE , Caplan A, Shofer F, Behrman AJ, et al
Physician attitudes towards influenza immunization and vaccine mandates.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

KWONG JC , Ge H, Rosella LC, Guan J, et al
School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: An ecological study.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

AMENDOLA A , Pariani E, Vigano A, Erba P, et al
Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SOUZA AR , Braga JA, de Paiva TM, Loggetto SR, et al
Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
Vaccine. 2010;28:1117-20.
PubMed Text format Related articles Abstract available

BAGUELIN M , Hoek AJ, Jit M, Flasche S, et al
Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

SCHMEISSER F , Vodeiko GM, Lugovtsev VY, Stout RR, et al
An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

CHEN Y , Wu J, Yi QL
Reduced risk of hospitalization associated with influenza vaccination in Canada.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

BRAHMAKSHATRIYA VR , Lupiani B, Reddy SM
Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

JOO HM , He Y, Sundararajan A, Huan L, et al
Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination.
Vaccine. 2010.
PubMed Text format Related articles Abstract available

December 2009

DINH A , Lawrence C, Salomon J, Descatha A, et al
Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital.
Vaccine. 2009.
PubMed Text format Related articles

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Flying Publisher website.
Design: